The effect of phospholipase C on the responsiveness of cardiac receptors. I. Inhibition of the adrenergic inotropic response.
D000818:Animals; D002118:Calcium / Q000502:physiology; D002642:Chick Embryo; D003864:Depression, Chemical; D016650:Fluorescein-5-isothiocyanate; D005452:Fluoresceins; D006321:Heart / Q000187:drug effects* / Q000294:innervation; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008563:Membrane Lipids / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism; D010713:Phosphatidylcholines / Q000494:pharmacology; D010740:Phospholipases / Q000494:pharmacology*; D010743:Phospholipids / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013861:Thiocyanates; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D005452:Fluoresceins; D008563:Membrane Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; D013861:Thiocyanates; D011433:Propranolol; D010740:Phospholipases; D010738:Type C Phospholipases; D016650:Fluorescein-5-isothiocyanate; D007545:Isoproterenol; D002118:Calcium